Skip to main content
Winner Medical Co., Ltd. logo

Winner Medical Co., Ltd. — Investor Relations & Filings

Ticker · 300888 ISIN · CNE1000047Z8 LEI · 3003001HWYP0KVG4J717 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 737 across all filing types
Latest filing 2026-05-14 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300888

About Winner Medical Co., Ltd.

https://www.winnermedical.com

Winner Medical Co., Ltd. specializes in the research, development, manufacturing, and distribution of cotton-based medical dressings and consumer health products. The company operates through two primary segments: medical supplies and consumer goods. Its medical portfolio includes high-quality wound care products, surgical kits, and infection prevention supplies such as masks and protective gowns. Under its PurCotton brand, the company produces a wide range of consumer items, including cotton tissues, feminine care products, and baby care essentials, utilizing proprietary non-woven cotton technology. Winner Medical emphasizes the use of natural materials to provide safe, comfortable, and environmentally friendly solutions. The company maintains a vertically integrated supply chain and adheres to international quality standards, serving healthcare institutions and retail markets worldwide with a focus on hygiene and skin-friendly applications.

Recent filings

Filing Released Lang Actions
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled “2025年年度股东会决议公告” and provides detailed voting results for each proposal at the Annual General Meeting, including vote counts, percentages, and procedural assurances. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-14 Chinese
关于回购股份用于注销并减少注册资本暨通知债权人的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement by the company and its board regarding an open‐market share repurchase plan to cancel the repurchased shares and reduce registered capital, including creditor notification procedures under Company Law. This is a classic ‘transaction in own shares’ (share buyback and cancellation). Therefore, it falls under the ‘POS’ category.
2026-05-14 Chinese
关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 85% confidence The document is a stock exchange announcement by the company regarding its planned share repurchase (for cancellation) and discloses the top ten shareholders and top ten unrestricted shareholders as of the record date. This corresponds to a company buying back its own shares disclosure. Under the classification scheme, this is a Transaction in Own Shares (POS).
2026-05-11 Chinese
关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the shareholding situation of the top ten shareholders and top ten unrestricted shareholders prior to a share repurchase plan. It references a board meeting decision about share repurchase and provides detailed shareholding tables. The content focuses on share ownership details related to a share buyback but does not report financial results or earnings. It is not a full financial report, earnings release, or management discussion. It is not a regulatory certification or a report publication announcement. The document fits the category of Transaction in Own Shares (POS), which covers company announcements about share repurchases or related shareholding changes.
2026-05-08 Chinese
2025年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2025 年度内部控制自我评价报告' which translates to '2025 Annual Internal Control Self-Evaluation Report'. It references internal control evaluation based on regulatory requirements from the Shenzhen Stock Exchange and relevant Chinese corporate governance laws. The content details the company's internal control systems, evaluation scope, methodology, and conclusions about the effectiveness of internal controls over financial reporting and non-financial reporting. It includes detailed descriptions of governance structure, risk assessments, and internal control deficiencies, concluding no major defects were found. This type of document is a standalone audit-related report focusing on internal control evaluation rather than a full annual report or financial statement. It is not an announcement or a brief summary but a comprehensive internal control evaluation report. Therefore, it fits best under the category 'Audit Report / Information (AR)', which includes standalone audit reports and internal control evaluations. FY 2025
2026-04-21 Chinese
2025年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 95% confidence The document is titled as a summary table of non-operating fund occupation and other related party fund transactions for the year 2025, with detailed financial data including beginning balances, transaction amounts, interest, repayments, and ending balances. It contains substantive financial data and analysis related to the company's financial dealings with related parties. There is no indication that this is an announcement or a brief summary; rather, it is a detailed financial report for a specific fiscal year period. The content aligns with a comprehensive financial report for a period shorter than a full fiscal year (the year 2025), focusing on financial data and analysis. Therefore, it fits best under the category of Interim / Quarterly Report (IR). FY 2025
2026-04-21 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.